Seda Erem Basmaz
Research Subjects
Research Interests
Seda Erem Basmaz has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Göknur Yorulmaz
Eskisehir Osmangazi University
2 shared publications - Mustafa Eroğlu
BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTES
2 shared publications - Adile Begüm Bahçecioğlu
Department of Endocrinology and Metabolism, Gülhane Training and Research Hospital, University of Health Sciences, Ankara 06010, Türkiye
1 shared publication - Adnan Batman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Acibadem University School of Medicine, Istanbul, Türkiye
1 shared publication - Ahmet Toygar Kalkan
Eskisehir Osmangazi University
1 shared publication - Ahmet Yesilyurt
Acibadem Labgen Genetic Diagnosis Center Istanbul Türkiye
1 shared publication
Latest Publications
- Open Access
- 17 November 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (6)
Dermatological manifestations of hypoparathyroidism: a multicenter study
- 17 November 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (6)
Open AccessDermatological manifestations of hypoparathyroidism: a multicenter study
- Open Access
- 20 May 2025
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
- Vol. 29 (3) , 283-284
CHEK2 Mutation with Heterozygote c.592+3A>T Variant in a Patient with Early Breast and Papillary Thyroid Cancer
Cite this article as: Caklili OT, Metli K, Basmaz SE, Kurt AMO, Yesilyurt A. CHEK2 mutation with heterozygote c.592+3A>T variant in a patient with early breast and papillary thyroid cancer. Endocrinol Res Pract. 2025;29(3):283-284.
- 20 May 2025
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
- Vol. 29 (3) , 283-284
Open AccessCHEK2 Mutation with Heterozygote c.592+3A>T Variant in a Patient with Early Breast and Papillary Thyroid Cancer
Cite this article as: Caklili OT, Metli K, Basmaz SE, Kurt AMO, Yesilyurt A. CHEK2 mutation with heterozygote c.592+3A>T variant in a patient with early breast and papillary thyroid cancer. Endocrinol Res Pract. 2025;29(3):283-284.
- Open Access
- 1 January 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- No. Early Acce
Association of Hepatitis B Virus Polymerase/Surface Gene Overlap Mutations Developed in Nucleos(t)id Analogue Treatments of Chronic Hepatitis B with Hepatocellular Carcinoma
Aim: Nucleos(t)id analogs (NA) used in hepatitis B virus (HBV) treatment may cause rtA181T and sW172* mutations. sW172* increases progression to hepatocellular carcinoma (HCC). This study aimed to reveal the rtA181T/sW172* mutation in HCC patients on the background of chronic hepatitis B (CHB) to determine its association with NA. Material and Methods: A total of 90 CHB patients, 42 patients with HCC (DNA of 4 patients could not be analyzed), and 48 patients without HCC as the control group, were included in this study. Patients in the control group were divided into two groups, those who received NA treatment (n=21) and those who did not (n=21). Drug resistance analysis was performed by DNA sequencing. Results: Among the 42 patients with HCC, the median age was 63 (range, 37-81) years, and the median HBV DNA level was 6.0x106 (range, 30-1.14x108) IU/ml. In the 48 patients included as controls, the median age and HBV DNA level were 46 (range, 20-75) years and 1.41x107 (range, 80-1.70x108) IU/ml in the treatment-naive patients, and 36 (range, 21-50) years and 7.6x106 (range, 15.9x102 - 5.1x107) IU/ml in the NA-treated patients, respectively. sW172* mutation, which causes rtA181T mutation to occur, was identified in only 2 (5.3%) patients in the study group with HCC. Conclusion: Association between HCC and rtA181T/sW172* mutation suggests that HCC may develop in patients under NA treatment. The rtA181T/sW172* mutation should be screened in patients receiving treatment, and when detected, they should be closely monitored for HCC development.
- 1 January 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- No. Early Acce
Open AccessAssociation of Hepatitis B Virus Polymerase/Surface Gene Overlap Mutations Developed in Nucleos(t)id Analogue Treatments of Chronic Hepatitis B with Hepatocellular Carcinoma
Aim: Nucleos(t)id analogs (NA) used in hepatitis B virus (HBV) treatment may cause rtA181T and sW172* mutations. sW172* increases progression to hepatocellular carcinoma (HCC). This study aimed to reveal the rtA181T/sW172* mutation in HCC patients on the background of chronic hepatitis B (CHB) to determine its association with NA. Material and Methods: A total of 90 CHB patients, 42 patients with HCC (DNA of 4 patients could not be analyzed), and 48 patients without HCC as the control group, were included in this study. Patients in the control group were divided into two groups, those who received NA treatment (n=21) and those who did not (n=21). Drug resistance analysis was performed by DNA sequencing. Results: Among the 42 patients with HCC, the median age was 63 (range, 37-81) years, and the median HBV DNA level was 6.0x106 (range, 30-1.14x108) IU/ml. In the 48 patients included as controls, the median age and HBV DNA level were 46 (range, 20-75) years and 1.41x107 (range, 80-1.70x108) IU/ml in the treatment-naive patients, and 36 (range, 21-50) years and 7.6x106 (range, 15.9x102 - 5.1x107) IU/ml in the NA-treated patients, respectively. sW172* mutation, which causes rtA181T mutation to occur, was identified in only 2 (5.3%) patients in the study group with HCC. Conclusion: Association between HCC and rtA181T/sW172* mutation suggests that HCC may develop in patients under NA treatment. The rtA181T/sW172* mutation should be screened in patients receiving treatment, and when detected, they should be closely monitored for HCC development.
- Open Access
- 25 April 2023
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 108 (10) , e1013-e1026
Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study
Context: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism. Methods: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19–related SAT (Cov-SAT), SARS-CoV-2 vaccine–related SAT (Vac-SAT), or control SAT (Cont-SAT) groups. Results: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism. Conclusion: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19– and SARS-CoV-2 vaccine–related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.
- 25 April 2023
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 108 (10) , e1013-e1026
Open AccessSubacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study
Context: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism. Methods: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19–related SAT (Cov-SAT), SARS-CoV-2 vaccine–related SAT (Vac-SAT), or control SAT (Cont-SAT) groups. Results: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism. Conclusion: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19– and SARS-CoV-2 vaccine–related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.
- Open Access
- 17 January 2022
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 5 (1) , 189-194
Relationship between mental symptoms, dietary compliance and glucose levels of diabetic patients in isolation during COVID-19 pandemic
Aim: Coronavirus disease 2019 (COVID-19, 2019-nCoV) which first appeared in Wuhan, China in December 2019 is a disease causing acute respiratory failure. Home isolation methods are used to control the disease all around the world and also in our country. In this study we planned to explain the relationship between some mental symptoms, diet compliance, frequency of blood glucose measurement and blood glucose levels in diabetic patients during home isolation. Material and Method: In this study some questions about the frequency of blood glucose measurement, blood glucose levels, dietary compliance and mental states of the patients were asked on the phone and the patients were asked to give a score to the symptom severity. The notes were retrospectively screened. Results: It is known that social isolation triggers the anxiety and depression. Anxiety and depression can increase the secretion of some hormones which leads high blood glucose levels (respectively 54.4% of those with 200-300 mg/dl, 91.7% of those with >300 mg/dl don't follow their diets) in diabetic patients. These symptoms can reduce dietary compliance and frequency of the blood sugar measurement, therefore can make metabolic control of the diabetes difficult. Conclusion: In this study, we found that blood glucose levels were very high and the frequency of blood glucose measurements were very low in the patients who had some mood changes and we saw that the patients did not follow on their diets. It is important to support patients mentally during this process. Training and following up should be used with some various methods.
- 17 January 2022
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 5 (1) , 189-194
Open AccessRelationship between mental symptoms, dietary compliance and glucose levels of diabetic patients in isolation during COVID-19 pandemic
Aim: Coronavirus disease 2019 (COVID-19, 2019-nCoV) which first appeared in Wuhan, China in December 2019 is a disease causing acute respiratory failure. Home isolation methods are used to control the disease all around the world and also in our country. In this study we planned to explain the relationship between some mental symptoms, diet compliance, frequency of blood glucose measurement and blood glucose levels in diabetic patients during home isolation. Material and Method: In this study some questions about the frequency of blood glucose measurement, blood glucose levels, dietary compliance and mental states of the patients were asked on the phone and the patients were asked to give a score to the symptom severity. The notes were retrospectively screened. Results: It is known that social isolation triggers the anxiety and depression. Anxiety and depression can increase the secretion of some hormones which leads high blood glucose levels (respectively 54.4% of those with 200-300 mg/dl, 91.7% of those with >300 mg/dl don't follow their diets) in diabetic patients. These symptoms can reduce dietary compliance and frequency of the blood sugar measurement, therefore can make metabolic control of the diabetes difficult. Conclusion: In this study, we found that blood glucose levels were very high and the frequency of blood glucose measurements were very low in the patients who had some mood changes and we saw that the patients did not follow on their diets. It is important to support patients mentally during this process. Training and following up should be used with some various methods.